#GLP-1
articles
Danish Study: 49% Stop Wegovy Within a Year, One in Four Restart
A nationwide Danish cohort finds high first-year semaglutide discontinuation, driven partly by cost and side effects, wi...
Eli Lilly's Foundayo Launch Puts UK Brokers on Counterfeit and Disclosure Watch
The UK debut of Eli Lilly's daily Foundayo pill could widen non-disclosure in life, travel and private medical insurance...
Eli Lilly's Foundayo Launch Puts UK Brokers on Counterfeit and Disclosure Watch
The UK debut of Eli Lilly's daily Foundayo pill could widen non-disclosure in life, travel and private medical insurance...
GLP-1 Drugs Are Moving Far Beyond Weight Loss — and Rewriting Chronic Disease Treatment
New trial data link semaglutide and tirzepatide to improvements in sleep apnea, kidney, liver and heart outcomes, recast...
Why Splitting a GLP-1 Pill to Microdose Is Unsafe
Cutting oral GLP-1 tablets destroys the SNAC delivery system that protects the drug in the stomach, leading to inconsist...
A Patient's Guide to GLP-1 Side Effects: From GI Upset to Rare Eye Risks
GLP-1 drugs are widely prescribed, but patients should understand the range of reported side effects — from common nause...
Bank of America Spends $250 Million a Year on Weight-Loss Drugs for Employees, CEO Says
The disclosure from CEO Brian Moynihan underscores how GLP-1 medications are reshaping corporate healthcare budgets and ...
Diabetes Market Surges Past $966 Billion as Patient Count Tops 537 Million
Global diabetes spending reached nearly $966 billion in 2021, driven by a disease burden affecting 10% of the world's po...
Eli Lilly's GLP-1 Juggernaut Powers 48% Revenue Jump, Eyes Next Obesity Blockbuster
Quarterly sales topped $23 billion as Mounjaro and Zepbound dominate the obesity drug market. With a new oral pill and a...
ADA Review, Retatrutide Access and GLP-1 Generics Lead a Busy Diabetes Week
A busy week for diabetes and obesity drugs: ADA reviews a police incident, Lilly expands retatrutide access, Novo faces ...
Harris Teeter Now Delivers Prescriptions With Instacart Grocery Orders
Harris Teeter will deliver eligible prescriptions alongside Instacart grocery orders — its second pharmacy expansion in ...
Novo Nordisk Sheds $30 Billion as Heart Drug Trial Fails, Derailing Diversification Hopes
A late-stage trial of Novo Nordisk's cardiovascular drug ziltivekimab failed to meet its primary goal, wiping out a pote...
Aging Is a Controllable Biological System — Here’s How Science Says You Can Stabilize It
Research now frames aging as a dynamic system driven by metabolism, chronic inflammation, and epigenetic regulation. Thi...
The GLP-1 Paradox: MassHealth Cuts Coverage as Obesity Drugs Strain Budgets
MassHealth will stop covering GLP-1 obesity medications, saving $15M a year but affecting 22,000 residents – a microcosm...